.png){kind=logo}
SEDEMAC plans to raise Rs. 1,087.45 crore and shows sharp profit growth with strong return ratios and low debt.
Acetech and Striders operate in the SME segment, where smaller size and liquidity can lead to higher volatility after listing.
MiniMed Group aims to raise about $901.6 million on NASDAQ, offering investors exposure to global markets.
The first week of March brings a busy IPO calendar in Indian exchanges and the US market. Investors have options in auto electronics, e-commerce, toy distribution, and medical technology. From a large issue like SEDEMAC to SME offerings such as Acetech and Striders, and a major NASDAQ listing from MiniMed Group, you will find diverse opportunities.
Here’s a clear look at the key public issues open or closing between March 1 and March 6, 2026, and what traders should track.
SEDEMAC IPO opens on March 4 and closes on March 6. The company plans to raise about Rs. 1,087.45 crore through a book-building issue. The price band is set at Rs. 1,287 to Rs. 1,352 per share, with a face value of Rs. 10. The shares will list on BSE and NSE, and allotment is expected on March 9, with listing on March 11.
SEDEMAC supplies electronic control units to large Original Equipment Manufacturers (OEMs) in the mobility and industrial sectors in India, the US, and Europe. Its product range includes engine control systems, motor control units for EVs, and generator controllers. The company reported revenue of Rs. 662.54 crore in FY25, up from Rs. 535.90 crore in FY24. Net profit rose sharply to Rs. 47.05 crore in FY25 from Rs. 5.88 crore in FY24.
Return ratios are steady, with ROE at 22.01% and ROCE at 33.79%. Debt remains low with a debt-to-equity ratio of 0.21. The minimum lot size is 11 shares, which means a retail investor needs about Rs. 14,872 at the upper band. For investors looking at auto and EV-linked themes, this IPO may draw strong interest.
Acetech E-Commerce IPO opened on February 27 and will close on March 4. The issue size is around Rs. 49 crore, fully fresh issue. The price band is Rs. 106 to Rs. 112 per share. Listing is scheduled on NSE SME on March 9, with allotment on March 5.
The company operates in online and offline trading of consumer products. It handles sourcing, packaging, marketing, and sales across multiple platforms. Revenue rose from Rs. 60.28 crore in FY24 to Rs. 70.41 crore in FY25. Net profit increased to Rs. 6.88 crore in FY25 from Rs. 4.02 crore a year earlier.
Return on equity is at 73.75%, which is strong. EPS for FY25 is Rs. 7.64. The minimum application is 2,400 shares, which requires Rs. 2,68,800 at the top band. SME IPOs often see high volatility after listing, so traders should plan entry and exit levels in advance.
Also Read: Dell’s Fiscal 2026 Earnings Exceed Expectations, fueled by $64B in AI server orders and 39% growth
Striders Impex IPO closes on March 2. The issue size is about Rs. 36 crore, which includes a fresh issue of Rs. 31 crore and an offer for sale of up to 5,08,800 shares. The price band is Rs. 71 to Rs. 72 per share, and listing is set for March 6 on NSE SME.
The company focuses on licensing, brand development, and distribution of toys and kids’ products. It supplies to large retail chains and plans to expand its reach in India and overseas. For FY25, revenue came in at Rs. 61.95 crore, with net profit at Rs. 8.41 crore.
Return on equity is high at 55.81%. The debt-to-equity ratio is 1.36, which investors should note. The minimum lot size is 3,200 shares, which means a retail investor needs Rs. 2,30,400 at the upper price. The allotment date is March 4. Those looking at consumer and retail themes may track subscription levels closely before applying.
In the US market, MiniMed Group has filed for listing on NASDAQ under the symbol MMED. The company plans to offer 28 million shares in the price range of $25 to $28 per share, targeting around $901.6 million in total proceeds. There is also an option for over-allotment of 4.2 million shares. The IPO opens on March 6.
MiniMed is a global medical technology company focused on diabetes management systems. It has around 8,000 employees and operates in many countries. The firm designs and sells integrated diabetes care solutions, including dosing algorithms based on real-world data. For global investors, this is a large healthcare listing with a 180-day lock-in period. The scale of the offering and sector focus may attract institutional interest.
Also Read: Fundings Weekly Roundup: Axelera AI Pulls in Over $250 Million, Tattvam AI Raises $1.7 Million
This week offers both mainboard and SME IPO opportunities. SEDEMAC stands out for size and sector strength. Acetech and Striders offer smaller, growth-focused plays but come with SME risks. MiniMed provides exposure to global healthcare.
Before applying, investors should check valuation, lot size, and risk appetite. Listing gains are not guaranteed. Long-term investors should focus on revenue growth, profit trends, and balance sheet strength.
1. What are the top IPOs to watch now?
In the first week of March 2026, a few IPOs stand out. SEDEMAC Mechatronics is the largest mainboard issue this week. Acetech E-Commerce and Striders Impex are SME IPOs with smaller issue sizes but higher lot requirements. In the US market, MiniMed Group plans a large healthcare listing on NASDAQ. Investors can review these options based on size, sector, and risk level.
2. When does SEDEMAC IPO open?
SEDEMAC Mechatronics IPO opens on March 4 and closes on March 6. The company plans to raise about Rs. 1,087.45 crore. The price band is Rs. 1,287 to Rs. 1,352 per share. Allotment is expected on March 9, and listing is likely on March 11 on BSE and NSE. Investors should check the lot size and total investment amount before applying.
3. Are SME IPOs risky?
SME IPOs can be more volatile than mainboard IPOs. These companies are smaller in size and may have limited trading volume after listing. Price movements can be sharp in the first few days. Acetech and Striders both require higher minimum investment amounts due to large lot sizes. Investors should review financials carefully and apply only if they understand the risks.
4. Should I invest in MiniMed Group IPO?
MiniMed Group plans to list on NASDAQ and aims to raise about $901.6 million. The company works in diabetes management technology and operates globally. Investors who want exposure to international healthcare markets may find it interesting. However, global IPOs can carry currency and market risks. It is important to review valuation and long-term growth before making a decision.
5. How should investors select an IPO?
Investors should start by checking company fundamentals such as revenue growth, profit, and debt levels. They should also look at sector outlook and valuation compared to peers. Mainboard IPOs like SEDEMAC may offer more stability, while SME IPOs may carry higher risk and reward. A clear financial goal and risk tolerance can help in making the right choice.
Join our WhatsApp Channel to get the latest news, exclusives and videos on WhatsApp
_____________
Disclaimer: Analytics Insight does not provide financial advice or guidance on cryptocurrencies and stocks. Also note that the cryptocurrencies mentioned/listed on the website could potentially be risky, i.e. designed to induce you to invest financial resources that may be lost forever and not be recoverable once investments are made. This article is provided for informational purposes and does not constitute investment advice. You are responsible for conducting your own research (DYOR) before making any investments. Read more about the financial risks involved here.
